Lymphoma Follicular

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2021-12-17
EMA Authorised: Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) (lenalidomide hydrochloride monohydrate) — Krka, d.d., Novo mesto
EMA authorised lenalidomide Krka d.d. Novo mesto for indications including multiple myeloma and follicular lymphoma, establishing its market…